| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/06/2006 | US7056674 Prediction of likelihood of cancer recurrence |
| 06/06/2006 | US7056673 Preservation of RNA in a biological sample |
| 06/06/2006 | US7056672 insertion of nucleotides into genetic vectors comprising nucleotide sequences, then transfection into host cells, culturing under conditions permitting gene expression and analyzing for labelled polypeptides; genetic engineering |
| 06/06/2006 | US7056671 mixing deoxyribonucleotide triphosphates, polymerase, complementary sequences and ribonucleases, then incubating the mixture to generate reaction products; biosynthesis; genetic engineering |
| 06/06/2006 | US7056670 Involves immobilizing a molecule, incubation with distinguishable reporter moieties, detecting incorporation of the reporter moieties, elimination of the reporter moieties |
| 06/06/2006 | US7056669 Which are coupled to electrodes via conductive oligomers for detection of hybridization; site directed mutagenesis |
| 06/06/2006 | US7056667 Spatial learning and memory |
| 06/06/2006 | US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 06/06/2006 | US7056664 analyzing hybridization of deoxyribonucleic acids, ribonucleic acids or peptide nucleic acid with complementary strands which are joined to electroconductive support surfaces and to redox systems; electrochemistry |
| 06/06/2006 | US7056663 Diagnosing mammary gland cancer in humans; obtain target cells, obtain nucleotide sequences, screen for deletion of heterozygosity anf preferential chromosomal position, classify sample, loss of heterozygosity indicate tumor |
| 06/06/2006 | US7056662 Reducing the level of circulating free fatty acids by administering a compound that inhibits mal1, especially inhibiting transcription or translation of mal1 |
| 06/06/2006 | US7056661 Method for sequencing nucleic acid molecules |
| 06/06/2006 | US7056660 in vitro diagnosis of cancer and the use of cancer cells for screening drugs having antitumor or anticarcinogenic effects comprising analyzing or determining the presence or expression in body fluid cells of cancer-specific gene that is not expressed in non-cancer cells |
| 06/06/2006 | US7056659 Characterizing nucleic acids |
| 06/06/2006 | US7056658 Epitope sequence for use as tool in diagnostic analysis |
| 06/06/2006 | US7056657 Isolating magnetically labeled substances of interest from a non-magnetic test medium by means of high gradient magnetic separation (HGMS) |
| 06/06/2006 | US7056655 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 06/06/2006 | US7056654 Screening assay for inhibitors of human cytochrome P-450 |
| 06/06/2006 | US7056653 Detection of binding of charged species using PH- or potential-sensitive probes |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | US7056425 Air aperture in sample supplying passageway; electrolytic cells |
| 06/06/2006 | CA2388780C Binding acceleration techniques for the detection of analytes |
| 06/06/2006 | CA2363493C Attenuated forms of bovine viral diarrhea virus |
| 06/04/2006 | CA2524565A1 Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants |
| 06/03/2006 | CA2526272A1 Polypeptides involved in candida biofilm formation and uses thereof |
| 06/01/2006 | WO2006058263A2 Sensing phage-triggered ion cascade (septic) |
| 06/01/2006 | WO2006058246A2 System and method for replicating a bio-molecular micro-array |
| 06/01/2006 | WO2006058202A2 Mer diagnostic and therapeutic agents |
| 06/01/2006 | WO2006058048A2 Method of determining a cellular response to a biological agent |
| 06/01/2006 | WO2006058031A2 Microarray quality control |
| 06/01/2006 | WO2006057918A2 Detection of nucleic acid variation by cleavage-amplification method |
| 06/01/2006 | WO2006057763A2 Method for predicting g-protein coupled receptor-ligand interactions |
| 06/01/2006 | WO2006057722A1 Biosensors comprising semiconducting electrodes or ruthenium containing mediators and method of using the same |
| 06/01/2006 | WO2006057633A2 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly. |
| 06/01/2006 | WO2006057444A1 Method of automatically evaluating differentiation degree of cells |
| 06/01/2006 | WO2006057391A1 Method of detecting interaction between proteins |
| 06/01/2006 | WO2006057377A1 Method of measuring cholesterol in remnant-like lipoproteins |
| 06/01/2006 | WO2006057253A1 Microbe counting method and microbe counting device |
| 06/01/2006 | WO2006056948A1 Method for chemically activating molecules or protecting active molecules |
| 06/01/2006 | WO2006056853A1 Methods for cultivating lawsonia intracellularis |
| 06/01/2006 | WO2006056839A1 Human obesity susceptibility gene encoding a member of the neurexin family and uses thereof |
| 06/01/2006 | WO2006056825A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 06/01/2006 | WO2006056787A1 A device for carrying out a biological assay |
| 06/01/2006 | WO2006056766A2 Diagnosis of prostate cancer |
| 06/01/2006 | WO2006056701A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | WO2006056663A1 Method of screening compounds for the treatment of diabetes |
| 06/01/2006 | WO2006056597A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | WO2006056490A1 Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrate |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |
| 06/01/2006 | WO2006056478A1 Kits and methods for detecting methylated dna |
| 06/01/2006 | WO2006056368A1 Method for identifying and treating photodamaged skin |
| 06/01/2006 | WO2006056340A2 Method for determining genotoxicity |
| 06/01/2006 | WO2006056080A1 Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis |
| 06/01/2006 | WO2006056061A1 Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| 06/01/2006 | WO2006056037A1 Method of detecting kidney dysfunction |
| 06/01/2006 | WO2006056028A2 Autism genes and regulated secretion |
| 06/01/2006 | WO2006056007A1 Inhibitors of biotin protein ligase |
| 06/01/2006 | WO2006047787A3 Method for monitoring disease progression or recurrence |
| 06/01/2006 | WO2006039190A3 System and method for image analysis of slides |
| 06/01/2006 | WO2006026735A3 Apparatuses and methods for analyzing gas exchange properties of biological fluids |
| 06/01/2006 | WO2006026222A3 Novel gene disruptions, compositions and methods relating thereto |
| 06/01/2006 | WO2006026074A3 Atherosclerotic phenotype determinative genes and methods for using the same |
| 06/01/2006 | WO2006023719A3 Identification of snp’s associated with schizophrenia, schizoaffective disorder and bipolar disorder |
| 06/01/2006 | WO2006021807A3 Methods of diagnosis of attention deficit hyperactivity disorder (adhd) |
| 06/01/2006 | WO2006020147A3 Use of pcr-based techniques to analyze compositions of botanicals |
| 06/01/2006 | WO2006015961A3 Enzyme-based time temperature indicator |
| 06/01/2006 | WO2006014723A3 Predicting alzheimer's disease |
| 06/01/2006 | WO2006014706A3 Methotrexate derivatives useful for treating cancer and arthritis |
| 06/01/2006 | WO2006013144A3 Method of in-vitro detection and quantification of hiv dna by quantitative pcr |
| 06/01/2006 | WO2006013103A3 Inducible gene expression |
| 06/01/2006 | WO2006007134A3 Jm-27 asa a marker of benign prostatic hyperplasia |
| 06/01/2006 | WO2005123958A3 Cd7 as biomarker and therapeutic target for psoriasis |
| 06/01/2006 | WO2005123779A3 Antibodies binding to cd34+/cd36+ fetal but not to adult cells |
| 06/01/2006 | WO2005121357A3 Diagnosis and prognosis of wound infection by measurement of a phospholipase a2 in wound fluid |
| 06/01/2006 | WO2005118870A3 Nanoscale electronic detection system and methods for their manufacture |
| 06/01/2006 | WO2005118845A3 Use of a genetic modification in the human gnaq gene for predicting risk of disease, the course of a disease, and reaction to treatments |
| 06/01/2006 | WO2005118796A3 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
| 06/01/2006 | WO2005116239A3 Diagnostic assays for neurodegenerative diseases |
| 06/01/2006 | WO2005115458A9 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
| 06/01/2006 | WO2005111241A3 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 06/01/2006 | WO2005108545A3 Devices for culturing anaerobic microorganisms and methods of using the same |
| 06/01/2006 | WO2005103692A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 06/01/2006 | WO2005103243A3 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets |
| 06/01/2006 | WO2005098041A3 Detection and treatment of fibrotic disorders |
| 06/01/2006 | WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 06/01/2006 | WO2005092038A3 Methods for the detection of nucleic acid differences |
| 06/01/2006 | WO2005090599A3 Methods and adaptors for analyzing specific nucleic acid populations |
| 06/01/2006 | WO2005076786A3 Colon carcinoma related oligonucleotides and methods of use |
| 06/01/2006 | WO2005048936A3 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof |
| 06/01/2006 | WO2005040397A3 Nucleic acid based nano-robotic system |
| 06/01/2006 | WO2005032495A3 Gene expression profiles and methods of use |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2004108896A3 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
| 06/01/2006 | WO2004093644A3 Methods and apparatus for genetic evaluation |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |